• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药物治疗重度抑郁症的六个月依从性。

Six-month compliance with antidepressant medication in the treatment of major depressive disorder.

作者信息

Demyttenaere Koen, Adelin Albert, Patrick Mesters, Walthère Dewé, Katrien De Bruyckere, Michèle Sangeleer

机构信息

University Hospital Gasthuisberg, Belgium.

出版信息

Int Clin Psychopharmacol. 2008 Jan;23(1):36-42. doi: 10.1097/YIC.0b013e3282f1c1d8.

DOI:10.1097/YIC.0b013e3282f1c1d8
PMID:18090506
Abstract

The investigation of compliance in patients with major depressive disorder (in drop-outs versus completers and in first episode versus recurrent episode patients). A total of 85 outpatients with major depressive disorder were followed for 6 months. Different dimensions of compliance were investigated: drop-outs versus completers and their medication adherence (with electronic monitoring). General linear mixed models were applied to examine the time courses of adherence. Drop-out rates were higher in younger patients and in patients with a lower initial depression severity. The adherence during 6 months of treatment with selective serotonin reuptake inhibitors was above 80 in 70% of the patients. The adherence decreased by 2.5% per month and decreased more than three times more rapidly in drop-outs (from baseline to time of drop-out). A medical visit resulted in a temporary increase in pill intake. General linear mixed model analysis showed that the predicted outcome was worse in drop-outs than in completers and worse in recurrent episode patients than in first episode patients (the former showing a higher adherence). Adherence decreases with time during 6 months of treatment with antidepressants and is influenced by demographic and clinical variables. Completers show a higher adherence than drop-outs. The outcome was worse in recurrent episode patients than first episode patients although they had a higher adherence.

摘要

重度抑郁症患者依从性的调查(脱落者与完成治疗者以及首发患者与复发患者)。共对85名重度抑郁症门诊患者进行了6个月的随访。研究了依从性的不同维度:脱落者与完成治疗者及其药物依从性(通过电子监测)。应用广义线性混合模型来检查依从性的时间进程。年轻患者和初始抑郁严重程度较低的患者脱落率较高。在70%的患者中,使用选择性5-羟色胺再摄取抑制剂治疗6个月期间的依从性高于80%。依从性每月下降2.5%,在脱落者中下降速度比这快三倍多(从基线到脱落时)。一次就诊导致药丸摄入量暂时增加。广义线性混合模型分析表明,脱落者的预测结果比完成治疗者差,复发患者的预测结果比首发患者差(前者依从性较高)。在使用抗抑郁药治疗的6个月期间,依从性随时间下降,并受人口统计学和临床变量影响。完成治疗者的依从性高于脱落者。复发患者的结果比首发患者差,尽管他们的依从性较高。

相似文献

1
Six-month compliance with antidepressant medication in the treatment of major depressive disorder.抗抑郁药物治疗重度抑郁症的六个月依从性。
Int Clin Psychopharmacol. 2008 Jan;23(1):36-42. doi: 10.1097/YIC.0b013e3282f1c1d8.
2
Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders.影响治疗抑郁障碍门诊患者抗抑郁药物依从性的因素。
J Affect Disord. 2010 Jun;123(1-3):216-21. doi: 10.1016/j.jad.2009.10.002. Epub 2009 Nov 14.
3
Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.艾司西酞普兰与西酞普兰治疗重度抑郁症的疗效及耐受性:一项针对成年门诊患者的为期6周的多中心、前瞻性、随机、双盲、活性药物对照研究。
Clin Ther. 2007 Nov;29(11):2319-32. doi: 10.1016/j.clinthera.2007.11.014.
4
Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.关于提高抑郁症患者依从性、自我管理能力及治疗效果的共识性建议。
CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27.
5
Adherence to antidepressant treatment.坚持抗抑郁治疗。
Expert Rev Neurother. 2007 Jan;7(1):57-62. doi: 10.1586/14737175.7.1.57.
6
Recovery from a recurrent major depressive episode.复发性重度抑郁发作后的康复。
Depress Anxiety. 2000;12(1):40-3. doi: 10.1002/1520-6394(2000)12:1<40::AID-DA5>3.0.CO;2-J.
7
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.中度抑郁症急性发作康复后使用金丝桃提取物 WS 5570 进行延续性和长期维持治疗——一项双盲、随机、安慰剂对照的长期试验。
Eur Neuropsychopharmacol. 2008 Nov;18(11):803-13. doi: 10.1016/j.euroneuro.2008.06.006. Epub 2008 Aug 9.
8
Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.短期动态疗法联合药物疗法治疗重度抑郁症:长期疗效
J Affect Disord. 2009 Apr;114(1-3):200-7. doi: 10.1016/j.jad.2008.07.010. Epub 2008 Aug 26.
9
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
10
[Treatment adherence in the recurrent depressive disorders].[复发性抑郁症的治疗依从性]
Encephale. 2002 May-Jun;28(3 Pt 1):255-9.

引用本文的文献

1
How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist.如何提高重度抑郁症患者对抗抑郁治疗的依从性:一份心理教育共识清单。
Ann Gen Psychiatry. 2020 Oct 12;19:61. doi: 10.1186/s12991-020-00306-2. eCollection 2020.
2
Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.精神障碍患者精神药物治疗不依从及其相关因素的系统评价和荟萃分析。
Syst Rev. 2020 Jan 16;9(1):17. doi: 10.1186/s13643-020-1274-3.
3
Identifying the Underlying Factors Associated With Patients' Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug Reviews.
识别与患者对抗抑郁药态度相关的潜在因素:患者药物评价的定性和定量分析
JMIR Ment Health. 2018 Sep 30;5(4):e10726. doi: 10.2196/10726.
4
Antipsychotic Medication Treatment Patterns in Adult Depression.抗精神病药物治疗成人抑郁症的模式。
J Clin Psychiatry. 2018 Mar/Apr;79(2). doi: 10.4088/JCP.16m10971.
5
HEDIS Antidepressant Measures Biased by 2013 Revision.2013年修订版导致医疗效果数据和信息集(HEDIS)抗抑郁药测量存在偏差。
J Manag Care Spec Pharm. 2015 May;21(5):365-6. doi: 10.18553/jmcp.2015.21.5.365.
6
New roles for pharmacists in community mental health care: a narrative review.药剂师在社区精神卫生保健中的新角色:一项叙述性综述。
Int J Environ Res Public Health. 2014 Oct 21;11(10):10967-90. doi: 10.3390/ijerph111010967.
7
Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study).社区药剂师干预抑郁症患者的成本效益:一项随机对照试验(PRODEFAR 研究)。
PLoS One. 2013 Aug 12;8(8):e70588. doi: 10.1371/journal.pone.0070588. eCollection 2013.
8
Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies.抑郁症患者抗抑郁药依从性的社会人口学和临床预测因素:观察性研究的系统评价
Patient Prefer Adherence. 2013;7:151-69. doi: 10.2147/PPA.S39382. Epub 2013 Mar 3.
9
Adherence to escitalopram treatment in depression: a study of electronically compiled dosing histories in the 'Depression: the search for phenotypes' study.抗抑郁药物依西酞普兰治疗的依从性:“抑郁症:表型研究”中电子编制剂量史研究。
Int Clin Psychopharmacol. 2012 Nov;27(6):291-7. doi: 10.1097/YIC.0b013e3283597678.
10
Antidepressant adherence: are patients taking their medications?抗抑郁药依从性:患者在服用药物吗?
Innov Clin Neurosci. 2012 May;9(5-6):41-6.